All posts by imreal

Health

What We Have Learned So Far, Upcoming Webinar Hosted by Xtalks

Leave a comment


Xtalks Life Science Webinars

Speakers will also share lessons learned from translating English plain language summaries, discuss common pitfalls and recommendations to avoid them.


Toronto, Ontario (PRWEB)

Anyone who has been involved in the process of creating a plain language summary understands the challenges it entails. How do you take a detailed document and translate it into a plain language summary understandable by lay readers and experts? How do you establish a process to create summaries of the right quality, on time and reliably?

In this free webinar, expert speakers will explore how the pharmaceutical industry is engaging with patients and patient advocates to produce high-quality plain language summaries. This live session will be held on Friday, December 6, 2019 at 9am EST (2pm GMT/UK) and features the following speakers:


  •     Debra Guerreiro, Associate Director, Plain Language Summary Program Lead, Janssen Data Transparency

  •     Dianne Beland, Senior Manager, Clinical Trial Data Sharing/Disclosure, Celgene Corporation

  •     Jessica Valencia, PhD, Operational Excellence Expert, Novartis Pharmaceuticals, Patient Engagement & Advocacy

  •     Vidhi Vashisht, Associate Director, Clinical Trial Disclosure, Development Operations, Kinapse, a Syneos Health Company

Speakers will also share lessons learned from translating English plain language summaries, discuss common pitfalls and recommendations to avoid them.

At the end of this session, there will be an open question and answer session for the speakers to address any problems and challenges you face in plain language summary projects.

For more information or to register for this event, visit Writing Plain Language Summaries for Clinical Trials: What We Have Learned So Far.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Health

Rodkeys and Massage Heights to Impact National CBD Sales With New Partnership

Leave a comment


“When people understand that CBD is non-intoxicating and that it prompts the body’s own Endocannabinoid System to do its job, it can help regulate a number of functions and ease ailments, they have a whole new array of options to assist them.


SAN ANTONIO, Texas (PRWEB)

San Antonio-based businesses, Rodkeys and Massage Heights, are about to make a big impact on national Cannabidiol (CBD) product sales through a new partnership announced today. This collaboration has the potential to expand the public’s exposure to and comfort with non-tetrahydrocannabinol (THC) CBD products.

A selection of Rodkeys branded non-THC CBD products are now available at more than 85 participating Massage Heights’ stores. An additional roll out to other Massage Heights stores in the company’s 140+ store network is in the works in states where non-THC CBD products are allowed by law.

“Like massage, CBD products are a great tool for alternative healing options,” said Brooke Riley, licensed massage therapist and operation specialist of Massage Heights. “We chose to partner with Rodkeys for this service because of their dedication to quality products and wellness education.”

Rodkeys is a plant-based health and wellness organization focused on promoting balance and vitality through the use of hemp-derived CBD products. Their quality assurance measures include tested and curated raw materials from vetted farms, a GMP certified local manufacturing lab, a Compound Pharmacist on staff, a Physicians Advisory Board, and two-level third-party testing to verify potency, no THC and no contaminants in all the products.

“As a wellness-focused institution, we assist everyday people who are becoming more familiar with the therapeutic potential of CBD,” said Charles Rodkey Jr., chief formulator and founder of Rodkeys. “The key is education and we personalize this to meet the needs of every client. When people understand that CBD is non-intoxicating and that it prompts the body’s own Endocannabinoid System to do its job, it can help regulate a number of functions and ease ailments, they have a whole new array of options to assist them. Partnering with Massage Heights is an important step in educating more people about CBD products and helping them to overcome common misconceptions.”

Interviews are available upon request.

Share article on social media or email:

Health

Nanotechnology for disease diagnosis and treatment earns Florida Poly professor international award

Leave a comment


Florida Poly assistant professor Dr. Ajeet Kaushik has received the 2019 Universal Scientific Education Research Network (USERN) Prize in biological sciences, an international award recognizing his work in the field of nanomaterials for the detection and treatment of diseases.

Dr. Ajeet Kaushik has received the 2019 USERN Prize in biological sciences.

“The drugs we use now do not go only where they need to go, or sometimes they have side effects. We are treating one disease but creating other symptoms. I’m exploring nanotechnology that can carry a drug, selectively go to a place, and release the drug so we avoid using excessive drugs.”


LAKELAND, Fla. (PRWEB)

Dr. Ajeet Kaushik is determined to make detecting and treating diseases easy, accessible, and precise through the use of nanomaterials for biosensing and medicine.

His extensive work and resolute desire to improve the delivery of healthcare has earned Kaushik the prestigious Universal Scientific Education Research Network (USERN) Prize. He was named a laureate in the field of biological sciences during the group’s fourth annual congress on Nov. 8 in Budapest, Hungary.

USERN, a non-governmental, non-profit organization and network dedicated to non-military scientific advances, is committed to exploring science beyond international borders.

“I was speechless for a while,” said Kaushik, who is an assistant professor of chemistry at Florida Polytechnic University.

Kaushik did not attend the awards ceremony in person but did submit a video to be played at the event. He was among hundreds vying for the prize and one of five people who were recognized in different areas of study.

His submitted project, Nano-Bio-Technology for Personalized Health Care, focuses on using nanomaterials to create biosensors that will detect the markers of a disease at very low levels.

“Biosensing is not a new concept, but now we are making devices that are smarter and more capable,” Kaushik said.

He cited the recent zika virus epidemic that affected pregnant women and their fetuses, leading to significant health complications upon birth. “There was a demand to have a system that could detect the virus protein at a very low level, but there was no device. There was no diagnostic system,” he said.

Kaushik worked on the development of a smart zika sensor that could detect the disease at these low levels. “The kind of systems I’m focusing on can be customized in a way that we carry like a cell phone and do the tests wherever we need to do them,” he said.

In addition to using nanotechnology for the detection of diseases like zika, his research on nanoparticles is advancing efforts to precisely deliver medicine to a specific part of the body without affecting surrounding tissue or other parts of the body.

“The drugs we use now do not go only where they need to go, or sometimes they have side effects. We are treating one disease but creating other symptoms,” Kaushik said. “I’m exploring nanotechnology that can carry a drug, selectively go to a place, and release the drug so we avoid using excessive drugs.”

This nanomedicine could be used to precisely target brain tumors or other difficult-to-treat conditions. He has published papers in scientific journals about this work and also holds multiple patents.

“My whole approach is using smart material science for better health for everybody, which is accessible to everybody everywhere,” Kaushik said.

In addition to his USERN prize, Kaushik was named a USERN junior ambassador for 2020 and will work to advance the organization’s mission in the United States.

For the most recent university news, visit Florida Poly News.

About Florida Polytechnic University:

Florida Polytechnic University is accredited by the Southern Association of Colleges and Schools Commission on Colleges and is a member of the State University System of Florida. It is the only state university dedicated exclusively to STEM and offers ABET accredited degrees. Florida Poly is a powerful economic engine within the state of Florida, blending applied research with industry partnerships to give students an academically rigorous education with real-world relevance. Connect with Florida Poly online at http://www.floridapoly.edu.

Share article on social media or email:

Industry: Healthcare

Introducing the BIXOLON XD5 Series of Desktop Label Printers

Leave a comment


Introducing the BIXOLON XD5 Series of Desktop Label Printers

BIXOLON XD5 Series

The NEW XD5 series fits user requirements for medium barcode printing within the Manufacturing, Logistics and Retail industries due to its compact clamshell design, high performance, easy operations and maintenance backed by BIXOLON’s technical support and service.


SONGNAM-SI, South Korea (PRWEB)

BIXOLON Co., Ltd, a leading global Mobile, Label and POS Printer manufacturer today announced the launch of the new XD5-series of desktop label printers. Featuring a compact, robust design with optional LCD Display and outstanding performance for medium volume printing applications.

The XD5-40d is the first model being brought to market from this mid-tier series, featuring a distinctive similar look with XD3 and XT5 series. This new 4-inch (118mm) direct thermal desktop label printer is available in 203dpi and 300dpi configurations; the XD5-40d and XD5-43d respectively. The standard XD5-40d model offers fast data processing and print speeds up to 7 ips (178 mm/sec) at 203 dpi to produce high quality printing text, graphics and industry standard 1D & 2D barcodes. Supporting an optional mono LCD display with intuitive icon driven menu for easier setup. The label printer is fully compatible with market-leading programming languages including SLCS, BPL-Z™, BPL-E™, while supporting Smart Switch Programming Language.

The XD5-series supports a media roll diameter up to 127 mm, with USB v2.0 and USB Host interfaces as standard. Plus optional Serial, 10/100 Ethernet, internal MFi certified Bluetooth v4.2 (Classic and LE) and dual-band 802.11a/b/g/n WLAN. Supporting a range of receipt, label, tag and wristband media, the XD5-series includes Peeler with full-width Auto Cutter options and External Paper Supply accessory. The XD5 is compatible with label design software including BIXOLON’s own Label Artist-II™, Label Artist™ Mobile and BarTender®. While supporting comprehensive software platforms Android, iOS, Windows, Linux, Chrome and Xamarin SDK. Plus, mPrint App and mPrint Server for mobile printing, alongside XPM™ and XCM™ for web-based device management. The label printer also offers easy toolless routines for easy cleaning or maintenance of the platen roller and printhead.

“BIXOLON’s is dedicated to providing a range of feature rich desktop label printing solutions which are available to all,” cites John Kim Marketing Director BIXOLON Ltd. “The NEW XD5 series fits user requirements for medium barcode printing within the Manufacturing, Logistics and Retail industries due to its compact clamshell design, high performance, easy operations and maintenance backed by BIXOLON’s technical support and service.”

For more information visit http://www.BIXOLON.com, subscribe to blog.bixolon.com, or alternatively speak to your local BIXOLON sales representative.

Availability

The XD5-40d is available for order for the BIXOLON Head Office sales region. The product will then be available to order from BIXOLON Europe and BIXOLON America’s sales regions from February 2019. For more information, contact your local BIXOLON sales representative.

About BIXOLON

BIXOLON is a leading global manufacturer of innovative, advanced printing technologies including point-of-sale receipt, label, Auto ID and mobile printers for a wide range of environments. Millions of BIXOLON printers are used today in retail, hospitality, healthcare, banking, ticketing, post/parcel, warehousing and other transaction-intensive industries. In 2019, for the sixth consecutive year BIXOLON was named global mobile receipt printer market leader by Japanese research company Chunichisha.

For more information visit http://blog.bixolon.com or alternatively speak to your local BIXOLON sales representative.

Share article on social media or email:

Health

Former NBA Player Kevin Ollie Partners with Modern Acupuncture to Make Lives Better, Especially for Stressed Out Youth

Leave a comment


Stress is a real issue affecting every part of our society and Modern Acupuncture is a potential solution for so many, especially for our youth who are more stressed-out than ever.


SCOTTSDALE, Ariz. (PRWEB)

Modern Acupuncture™, the nation’s first acupuncture franchise that aims to bring holistic treatment to the masses, has partnered with Kevin Ollie, former NBA player and former head coach for the University of Connecticut men’s basketball team, winning the 2014 NCAA National Championship, to raise awareness about the potential for holistic medicine to transform and save lives.

“My mission is to have Modern Acupuncture knock on every door and deliver a gift of holistic healing wrapped in self-care management. Being a former athlete and national championship-winning coach, I know that this can benefit all of us regardless of our age, gender, race or socioeconomic background,” said Ollie. “Stress is a real issue affecting every part of our society and Modern Acupuncture is a potential solution for so many, especially for our youth who are more stressed-out than ever. I am eager to do what I can to increase awareness and accessibility for all.”

In 2018 the U.S. Centers for Disease Control (CDC) published an alarming report that the suicide rate in the U.S. had increased by 30 percent over less than 20 years. Dr. Oren Miron from Harvard Medical School, further analyzed the CDC data to understand the impact on adolescents and young adults and found that in 2017 there was a 47 percent increase since 2000 in suicide deaths amongst the age range of 15-19. In fact, suicide is now the second-highest cause of death among people aged between 15-24. Dr. Michael Lindsey, Executive Director, McSilver Institute for Poverty Policy and Research and Constance and Martin Silver Professor of Poverty Studies, studied the impact on black teens and found that the rate of self-reported suicide attempts since 1991 had increased by 73 percent.

While it isn’t exactly clear what is driving these trends, a 2017 Gallup Poll found that eight out of 10 people reported feeling stressed during their day and 44 percent reported that their stress levels had increased over the last five years.

In a 2019 study, Modern Acupuncture identified that stress was one of the leading conditions in which patients sought treatment. Since opening in 2017, Modern Acupuncture has seen over 400,000 patients visits and over 25 percent of these visits were specifically for stress, and anxiety.

“We have been overwhelmed with the positive stories from our patients who have reported turning a corner after suffering from debilitating stress and anxiety’ said Matt Hale, CEO of Modern Acupuncture. “Acupuncture is a game-changer in many people’s lives, and we have developed an approachable solution at Modern Acupuncture that helps demystifies acupuncture in general. Many are adopting acupuncture into their lifestyle and routine as it serves as a tool for people that are dealing with pain and stress. Partnering with Kevin Ollie will continue to spread our mission of making lives better and help people of all ages and backgrounds across the nation.”

Ollie followed his passion and partnered with respected physician and entrepreneur Charles L. Anderson, MD, MPH, MBA to develop the third Modern Acupuncture location in New England in Burlington, Mass., located at the Village at Burlington Mall, scheduled to open in the first quarter of 2020.

“I partnered with Corey Bowdre (former Red Sox, Business Development) to help me bring as many people from across diverse backgrounds into this movement. Coach Ollie is a real guy, looking to make a real difference, and I am really fortunate to have him on my team,” said Dr. Anderson.

Unlike traditional acupuncture, a visit at Modern Acupuncture does not require the removal of any clothing to access full-body health. A visit to Modern Acupuncture™ feels like a relaxing retreat, where guests can unwind and possibly even fall asleep, zoning out to peaceful music all while experiencing the healing and/or cosmetic benefits of acupuncture. Sessions are typically 30 minutes or less, and walk-ins are welcome. For more information, please visit http://www.modernacupuncture.com.

About Modern Acupuncture™

Based in Scottsdale, Ariz., and founded in 2016, Modern Acupuncture™ is revitalizing the ancient practice of acupuncture for the modern individual by making all-natural health and beauty benefits available to the public in Zen-inspired clinics across the country. There are currently 51 clinics in the U.S. across 16 states, and a total of 165 licenses have been sold across 25 states.

Modern Acupuncture™ offers developer and franchisee opportunities to qualifying entrepreneurs. ACU Development, LLC is the franchisor of Modern Acupuncture™ franchise locations and an operator in some states. In California, Massachusetts, Nevada, New Jersey, New York, Tennessee, and Washington, ACU Development, LLC and its franchisees provide management services to affiliated professional acupuncture practices. For more information, please visit http://www.modernacupuncture.com.

Share article on social media or email:

Health

Smile Brands Opens New Aspire Dental Location in Irvine, CA

Leave a comment


Dr. Kawamoto

I believe in providing compassionate, quality care unique to each patient in a professional, fun and welcoming environment.


IRVINE, Calif. (PRWEB)

Smile Brands Inc., one of the nation’s leading providers of business support services to dental groups in the United States, today announced the grand opening of the first affiliated Aspire Dental office. This is the first office for the community of Irvine.

Patients will enjoy the convenient hours, comfortable office and full-service care at the new Aspire Dental office. This location provides full-service general dentistry, plus specialty care services, such as orthodontics (braces), Invisalign®, oral surgery, periodontics, endodontics, and implants. Located at 13234 Jamboree Road, in Irvine, the office will be open six days a week, including evenings and Saturdays. Aspire Dental accepts most major insurance plans and offers flexible financing options so patients can afford the care they need.

To celebrate the grand opening, the new Irvine dental office will offer a special $59 New Patient Check-Up Package, including an exam with oral cancer screening and digital x-rays, and Free Whitening for Life as long as patients maintain bi-annual teeth cleaning appointments.

Leading the clinical team in the new Aspire Dental office is Dr. Darcy S. Kawamoto. Dr. Kawamoto is an Irvine native with a passion for giving back. In addition to serving patients locally, Dr. Kawamoto has traveled to Nicaragua and Honduras on humanitarian mission trips to help local dentists provide care to the underserved.

“I believe in providing compassionate, quality care unique to each patient in a professional, fun and welcoming environment,” says Dr. Kawamoto. “I’m excited to partner with Smile Brands to open the first state-of-the-art Aspire Dental facility serving the community of Irvine.”

This new office is open on Mondays, Fridays and Saturdays from 8am – 5pm, Tuesdays and Thursdays from 9am – 6pm and Wednesdays from 10am – 7pm.

Prospective patients can call the new Irvine Aspire Dental office at 714-316-2966. People can also visit us online to schedule an appointment at the new Irvine location.

About Smile Brands Inc.

Based in Irvine California, Smile Brands Inc. is one of the largest providers of support services to dental groups in the United States. The culture-driven organization is the #1 ranked multi-location healthcare provider on Glassdoor’s 2019 Best Places to Work list. Smile Brands provides comprehensive business support services through exclusive long-term agreements with affiliate dental groups, so dentists can spend more time caring for their patients and less time on the administrative, marketing, and financial aspects of operating a dental practice. Smile Brands supports 440 Bright Now!® Dental, Monarch Dental®, Castle Dental®, A+ Dental Care, OneSmile Dental, Johnson Family Dental, P3 Dental Group, and DecisionOne Dental Partners offices in 18 states, including Arizona, Arkansas, California, Colorado, Florida, Illinois, Indiana, Maryland, Ohio, Oregon, Nevada, Pennsylvania, Tennessee, Texas, Utah, Virginia, Washington and Wisconsin. Smile Brands is a portfolio company of Gryphon Investors, a leading middle-market private equity firm based in San Francisco, CA. For more information, visit http://www.smilebrands.com.

Share article on social media or email:

Health

New York Gum and Dental Implant Specialist Dr. Bernard Fialkoff Organizes December 9th NYC Dentists Give Back Day to Help NYC Veterans

Leave a comment



QUEENS, N.Y. (PRWEB)

Dr. Bernard Fialkoff, a New York City Dental Implant, Periodontal and Laser Surgeon of 39 years organized and formed the NYC Dentists Give Back Group at the September meeting of the Fialkoff Dental Study Club. The group of dentists decided to offer no charge dental exams and cleanings to veterans and those in need of dental care as a Holiday Hanukkah and Christmas gift. They did so to acknowledge the Veterans’ selfless dedication to protect the freedoms we all enjoy in the United States of America.

Dr. Fialkoff states, “US Veterans risked their lives to safeguard our nation. But many go without dental care and are living with pain and suffering from infections caused by the lack of proper dental care.” Only 8% of all US Veterans get care from the VA and worse yet, US veterans account for 12% of the homeless population in the US. Many Veterans are unable to receive dental treatment from the Veterans Administration because of strict inclusion criteria. To help, the NYC Dentists Give Back Group members have organized and will be delivering these no charge services at their respective dental offices throughout all five Boroughs on December 9.

Harlem Globetrotter Robert Hunter, Metro Area Veteran Directors Johnnie Williams and Manuel Rodriguez, Development Manager of the Queens Chamber of Commerce Brendan Leavy, Hispanic Dental Association President Dr. Hanette Gomez, Past Presidents of Queens County Dental Society Dr. Robert Trager, Dr. Robert Shpuntoff and Dr. Maria Torres, both club members, and Dr. Bernard Fialkoff, all pledged themselves to make December 9 NYC Dentists Holiday Gift Give Back Day, a day to remember. The group has a new Facebook site: “New York City Dentists Give Back Group”.

Commissioner James Hendon, NYC Department of Veterans’ Services says, “NYC Department of Veterans Services’ Engagement and Community Service team will soon begin to actively spread the word about your event. Also, we will begin to promote the Holiday Humanitarian Day dental services that you are offering on social media. We truly appreciate your generosity in offering one day of free dental services to Veterans and vulnerable members of our society.”

Dr. Fialkoff states, “Each New Yorker is very important to the well being of our city. Life is a group effort and the success of any program begins with the individuals in those groups. Any worthwhile activity begins with individuals and then spreads to family, local groups, the city, the state and then nationally. As community members, we can feel proud of helping our community and improving our city. What better way is there to do this, than help to help the very people who fought for our country’s freedom – our own Veterans.”

Dr. Bernard Fialkoff was Valedictorian of the SUNY at Stony Brook Dental School Class of 1980. He trained and graduated from the Memphis Veterans Administration Hospital Periodontal and Implant Surgical Specialty program in Memphis, Tennessee in 1982, is a distinguished honoree of Pierre Fauchard, as well as a Member of the New York State Dental Association Chemical Dependency Committee.

Dr. Fialkoff’s practice welcomes new patients. The office dedicates itself to helping patients with periodontal, dental implant and cosmetic laser treatments that regain confidence and healthy smiles. For 39 years, at 56-03 214th Street, Bayside, NY, the practice has gained a reputation for honesty, integrity and providing excellent, high quality care in a calm and friendly environment. You can contact the office at (718) 229-3838 or office@bernardfialkoffdds.com.

For further information, the office web site and blog is http://www.baysidedentist.com. Dr. Fialkoff also has a web page devoted to his non-profit drug education program at: http://baysidedentist.com/our-office/community-drug-education-program/.

Share article on social media or email:

Business: Executives

The Harambee Opportunity Fund Launches and Seeks Opportunity Zone Investors for Waste to Energy Fund Projects, Industrial Parks, Green Energy and Social Enterprises

Leave a comment


So not only will the investment allow investors to participate in double the social impact through helping achieve educational, social, and economic uplift in north Huntsville, but the Harambee Opportunity Fund also allows for significant returns for investors while doing so.


HUNTSVILLE, Ala. (PRWEB)

The Harambee Opportunity Fund launches and seeks Opportunity Zone investors for Waste to Energy Fund projects, Industrial Parks, Green Energy and Social Enterprises. The Fund is authorized to raise $150 million and will co-invest in the USWTE Solutions Opportunity Fund to help solve social problems using a market driven approach.

Harambee Opportunity Fund Video: https://Vimeo.com/367104797

Nature of the Funds – Waste to Energy

The Huntsville Network for Urban School Renewal (“HNUSR”) is a social enterprise offering services that support and revitalize communities particularly for north Huntsville through the improvement of educational outcomes for children, youth and adults in those communities. In addition, HNUSR also seeks to intentionally leverage those improved outcomes to engage in community and economic development throughout the City of Huntsville, particularly North Huntsville, as part of an Opportunity Zone. Therefore, HNUSR uses as a framework a model by which it engages in entrepreneurial activities and generates social impact (e.g., investing in technologies that eliminate toxic waste with a focus on waste plastics and end of life tires from the United States and eventually the globe for the betterment of our planet). Funds generated are then used to support educational and other social programs provided to the targeted communities at no cost and to produce high returns for investors.

We are offering investors the opportunity to double the social impact they make and achieve significant returns on their investment by participating in the Harambee Opportunity Fund. The Harambee Opportunity Fund will co-invest in the USWTE Solutions Opportunity Fund and help fund Waste to Energy technology and Industrial Parks. The Fund will initially invest in the creation of WTE projects in Alabama. So not only will the investment allow investors to participate in double the social impact through helping achieve educational, social, and economic uplift in north Huntsville and through the opportunity to create a cleaner globe, but the Harambee Opportunity Fund also allows for significant returns for investors while doing so.

The Fund will not only address the social problem of toxic waste in the environment, but will leverage the WTE investment to address issues of low academic achievement, healthy food scarcity, and unemployment or underemployment in low-income communities by developing a 6-acre property in a Qualified Opportunity Zone that will allow to HNUSR to significantly expand on their social mission of mitigating poverty related factors that contribute to the low academic achievement of children, address healthy food scarcity, and increase employment skills and opportunities for individuals living in low income communities in Huntsville.

The Harambee Center will not only create 115 jobs (70 full-time and 40 part-time ) for the community that are high quality (i.e., all offering wages significantly above the state’s minimum wage), but through its workforce development programs will also create a pipeline of diverse, qualified and skilled workers from traditionally underserved communities for the city’s fast-growing economy. The WTE plants will create 40 to 100 skilled and unskilled local jobs at each facility with an average salary of $60,000, or an annual payroll ranging from $2.4M to $6M.

About Fund Manager

EDWARD L. JONES, PH.D

Fund Manager

Ed is an innovative, passionate and results-driven professional with over 25 years of experience in the field of education, as a public school teacher and professor and administrator in higher education institutions, and in nonprofit leadership. He has remained on the cutting edge of what is possible with social justice achievement when market-based approaches are married with social impact strategies, and leads a team of high-energy professionals who have redefined the possibilities for how the City of Huntsville, particularly, uses innovation to address issues of inequality in education and employment.

Ed holds the Doctor of Philosophy degree in Curriculum, Teaching & Educational Policy from Michigan State University, the Master of Science degree in Inorganic Chemistry from Clark Atlanta University, and the Bachelor of Science degree in Chemistry from Alabama A&M University.

CONNELLE BOONE

Investment Manager

Connelle has brought his technical training and experience in computer science and cybersecurity and combined that with his training and experience in business finance to serve as Investment Manager for the Harambee Opportunity Fund. Throughout his career, Connelle has worked in various positions in cybersecurity and finance for fortune 500 companies such as UPS, Boeing, and Lockheed Martin. Among his most recent experiences with Boeing, he assisted in configuring computer and computer networks and communications equipment and networks to facilitate data collection, storage and dissemination and worked to assist the company with a linked budget analysis software tool. He admits to being somewhat of a finance geek proudly proclaiming that profit and loss and profitability are specialty passions of his.

Connelle received a Bachelor of Science degree from North Carolina A&T State University and a Master of Business Administration degree with a concentration in program management from Colorado Technical University. He is currently completing studies towards a doctoral degree in Computer Science with a concentration in Cyber Security and Information Assurance from Colorado Technical University.

Essence Riley

Investment Analyst

Essence has a vision of helping change the world through financial literacy and financial planning. She recently interned with Monsanto in the area of Internal Audit where she compiled and analyzed financial transactions and prepared audit work papers in compliance with GAAP. She has also interned with the Tennessee Valley Authority in Corporate Business Planning & Analysis to provide analysis and reporting of performance metrics, gap/recovery plans and initiatives as needed, among other duties.

As Investment Analyst, Essence is tasked with researching, collecting and analyzing information which will help the Investment Manager make effective and profitable decisions on behalf of the Harambee Opportunity Fund particularly and HNUSR generally while building a successful investment portfolio.

Essence holds a bachelor’s degree in Finance from Alabama A&M University.

CHANDA DAVIS

Board Member

Chanda Davis is Licensed Realtor and Real Estate Broker at Chanda Real Estate and Superior School of Real Estate. With her entrepreneurial spirit, flare for innovation and expertise in education, Chanda brings a unique set of gifts to the Harambee Opportunity Fund Board of Managers that strengthens overall fund management for this particular fund. Chanda is also a nationally recognized instructor known for specializing in modern instruction geared towards real world learning.

In 2009, Chanda decided to combine her passion for teaching and real estate by becoming a certified instructor. She created a curriculum organized to target objectives for the licensing exams. She then formulated unique teaching strategies by merging her experience in education with the 17 plus years of experience in real estate. Chanda’s vision was to teach her students in a way that was not only valuable, but exclusive and enjoyable as well. She felt it was imperative that each student inherit the same “life changing” feeling that she did when she decided to start teaching real estate. That vision combined with her business savvy and entrepreneurial spirit produced the Superior School of Real Estate.

Chanda holds the Bachelor of Arts degree in Biology and Chemistry from the University of Alabama at Huntsville. She also earned a Master of Education degree from Alabama A&M University.

STANLEY B. STALLWORTH

Board Member

Stanley is the managing partner of The Stallworth Legal Group, LLC (“TSLG”), a law firm providing a wide range of transactional advice to clients in a myriad of areas, principally real estate and lending; and offers targeted advice in limited litigation matters and employment matters (including through affiliated law firms). After graduating in 1990 from the University of Wisconsin Law School, Madison, Wisconsin, Mr. Stallworth joined the Commercial Real Estate Practice at Sidley Austin, LLP in Chicago after having completed a summer associate clerkship at Sidley during 1989. As did 100 or so other eager 1989 summer associates, Stallworth served aside the person who would become the 44th President of the United States of America, Barack Obama, and his soon-to-be wife and First Lady, Michelle Robinson.

Currently, Stanley performs legal work for third-party owners and developers of real estate and for his own real estate development projects in Chicago and the southern region of the United States. Through his real estate development and consulting company, Stallworth Real Estate Development LLC., Stallworth currently is working to develop an apartment complex in his hometown of Evergreen, Alabama, and is working closely with the Evergreen Redevelopment Council to bring other real estate projects to fruition. He owns, operates and manages several residential, commercial and farmland properties.

DEFER CAPITAL GAINS TAX

Under the program, an investor can defer capital gains taxes until 2027 if realized gains are invested in a Qualified Opportunity Zone Fund within 180 days of the sale. Deferred gains owed are decreased by 10% after five years, and another 5% after seven years of investment. The deferred capital gains will be realized Dec. 31, 2026 and due by April 15, 2027.

ELIMINATE TAXES ON INVESTMENT

All capital gains taxes are eliminated after ten years of investment into a Qualified Opportunity Zone Fund (QOZF). Note: Investments into a QOZF do not have to be from capital gains to realize the ten year elimination of taxes.

A WIN/WIN SCENARIO

Opportunity Zones were designed to reward investors for investing in underdeveloped communities across America. The opportunity for everyone to win is here.

Investors

Generous incentives. The chance to profit and make an impact inline with the mission of the fund.

Entrepreneurs

Our funded companies receive the capital to execute their business plan and bring cutting edge products and services to market.

Communities

We are developing in areas ripe for revitalization from McMinnville and Medford Oregon, to Salinas, California, Las Vegas and beyond.

Consumers

We aim to deliver life changing products many Americans don’t know exist yet, but soon will.

About Harambee Opportunity Fund

Status: Open To Investors

Type of Fund: Stock (Class A 1:1 Common)

Asset Classification: Multiple Assets

Fund Focus: Waste to Energy & Education

Total Fund Size authorized: Uncapped

Total Fund Stock Available: $150M

Total Fund Stock Round A: $50M

Minimum Subscription: $100,000

Amount of Fund Spent: $0

Current Fund Equity: $0

Current Total Investments: 0

Active Potential Investments: 2

Fund Administration: NES Financial

Targeted Returns: 20%+

About EazyDoit Inc.

EazyDoit, Inc. is an opportunity fund creation company based in Virginia Beach, Va. EazyDoIt works with clients to develop a structured turn-key solution for business owners, real estate development projects, high net worth individuals and family offices looking to set up an opportunity fund experience. EazyDoit is recognized as a Top 10 OZ Influencer and is a leader in the Opportunity Fund Creation industry. CEO David Sillaman is a member of the Forbes Real Estate Counsel and EazyDoIt Funds have been recognized by FinTek News, Business Insider, Market Insider, Senior Housing News & Silicon Review to name a few. Mr. Sillaman is a frequent speaker at National Opportunity Zone Events, including the CDFA Florida Opportunity Zone Conference and past Opportunity Zone Expo Conferences. EazyDoIt has built one sixth (1/6) of all the opportunity funds in the market space today, with a strong emphasis on business based opportunity funds.

Please visit for more information:

Harambee Opportunity Fund: http://www.HarambeeOppFund.com

USWTE Green Industrial Fund at http://www.USWTE-Fund.com

EazyDoIt.com at http://www.EazyDoIt.com

Harambee Opportunity Zone, Inc. is a Qualified Opportunity Zone Fund.

Disclaimer:

Articles featured on this press release are for informational purposes only. This is not an offer to sell nor a solicitation to buy Harambee Qualified Opportunity Funds. That can only be done by our current Confidential Private Placement Memorandum (“CPOM”). Securities offered by Harambee Opportunity Fund Inc. For accredited Investors only. Limited liquidity. The shares being sold in this offering have not been approved or disapproved by the Securities and Exchange Commission or any state’s securities division. Nor has the Securities and Exchange Commission or any state securities department passed upon the accuracy or adequacy of the CPOM or the disclosures provided therein. Any representation to the contrary is a criminal offense. The information contained in this website is for general information purposes only. The information is provided by Harambee Opportunity Fund Inc. and while we endeavor to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

This Fund is 3rd Party Administered by NES Financial.

Health

MabPlex International Announces Appointment of Dr. Yongjian Wu (Ph.D.) as Chief Operating Officer of MabPlex USA

Leave a comment


News Image

We are very pleased that Dr. Wu has joined the MabPlex team. His extensive experience will play an important role in advancing MabPlex’s top-quality, global biopharmaceutical and biotechnology services while helping accelerate new drug development projects worldwide.


SAN DIEGO, Calif. and YANTAI, China (PRWEB)

MabPlex International, Ltd. (MabPlex), a leading, fully integrated, Contract Development and Manufacturing Organization (CDMO) serving the global biopharmaceutical and biotechnology industries with sites in China and the United States, today announced the appointment of Yongjian Wu, Ph.D. as Chief Operating Officer (COO) of MabPlex USA.

Dr. Wu’s appointment will add to the overall strength of MabPlex offering a top quality service to global biopharmaceutical and biotechnology companies, while helping to accelerate new drug development projects worldwide.

“MabPlex offers one of the few globally integrated service platforms with high production capacity, something that is unique in our industry,” said Dr. Wu.

“The company employs a world-class professional team with diverse project experience in Asia and abroad. With robust technical and quality systems, large-capacity current Good Manufacturing Practice (cGMP) facilities, and a wealth of experience in successful project execution and Investigational New Drug application (IND) submissions, MabPlex truly provides a one-stop CDMO service for biologics, especially for antibody-drug conjugates (ADCs). I am honored and excited to join MabPlex and hope to contribute to the growth of the company while further enhancing our capabilities to serve the international market,” said Dr. Wu concluded.

Extensive experience

Dr. Wu has more than 18 years of global biopharmaceutical experience. Before joining MabPlex, Dr. Wu worked at Bayer, BioMarin, Genentech and Tanvex, with both internal manufacturing and quality organizations for the production of preclinical/clinical and commercial-ready materials, as well as with external Contract Research Organization (CRO) for preclinical, bioanalytical and clinical development of pipeline projects. He has advanced numerous new drug development projects from early research/preclinical stage to IND and Biologics License Applications (BLA), authoring regulatory filings and interacting with agencies during face to face meetings and inspections.

Dr. Wu obtained his Ph.D. in Immunology at the University of Toronto, Canada, with Professor Nobumichi Hozumi, MD, Ph,D. He did his postdoctoral training in the Department of Neurobiology at Stanford University, Stanford, California with Professor Eric Manvers Shooter MA, Sc.D., D.Sc., FRS.

About MabPlex

MabPlex International Ltd (MabPlex), a leading and fully integrated, global Contract Development and Manufacturing Organization (CDMO), offers an advanced biologics platform and comprehensive and integrated solutions to global (bio-) pharmaceutical developers. Founded in 2013, MabPlex currently has two sites in China (Yantai and Shanghai) and one site in the United States (San Diego, CA) offering high quality services from biologics drug development to commercial manufacturing. MabPlex currently has over 60,000 square meters of R&D and production facilities, a total of 9 monoclonal antibody (mAb) Drug Substance (DS) production lines, 2 Antibody-drug Conjugate (ADC) DS production lines, as well as mAb formulation and ADC formulation lines. The commercial production service is designed to help customers accelerate the progress of clinical trials and support market launch.

MabPlex has established a talented team of more than 400 employees provideding Contract Development and Manufacturing Organization (CDMO) services to more than 40 pharmaceutical companies around the world resulting in more than 12 Investigational New Drug application (IND) approvals with the United States Food and Drug Administration (FDA), the Australian Therapeutic Goods Administration (TGA) and China’s National Medical Products Administration (NMPA). For more information, please visit our website at https://mabplexinc.com/

Share article on social media or email:

Health

Configo Health Launches with Investment from Texas Children’s Hospital and Children’s National Hospital

Leave a comment


“We are delighted to announce Texas Children’s Hospital and Children’s National Hospital, two of the top children’s hospitals in the nation, as our founding investors,” said Craig Manson, CEO of Configo Health.


WASHINGTON (PRWEB)

Configo Health Inc., a healthcare data and analytics company specializing in pediatrics, launched today and announced it has secured investment funding from Texas Children’s Hospital and Children’s National Hospital. The organization also appointed industry veteran Stephanie Alexander as Chair.

Configo Health addresses the lack of credible benchmarked data accessible both to administrators and clinicians working within pediatric hospitals and to patients and their families. Using both machine learning and more traditional retrospective analytics, Configo Health delivers actionable insight with near real-time relevance to improve patient safety and achieve better outcomes for children.

By creating a dataset that will cover the breadth of pediatric care, Configo Health will provide public ratings organizations with the option to use risk-adjusted performance data to assess the quality of care delivered by hospitals across the country more effectively.

“Today’s six month lag for benchmarked pediatric outcomes data just isn’t acceptable. Configo’s move to near real-time insight will be a game changer for driving improvement,” said Dr. Eric Williams, System Chief Quality Officer at Texas Children’s Hospital. “Quicker access to this validated data means more decisions can be made bedside leading to improved outcomes for the patients and families we serve.”

Experts in extracting administrative data from pediatric hospitals, Configo Health provides HIPAA-compliant processes, secure data storage facilities, data cleansing and sophisticated analytical processing. By analyzing and evaluating data, organizations can reduce serious safety events, reduce mortality rates, optimize length of stay and reduce readmissions.

“We are delighted to announce Texas Children’s Hospital and Children’s National Hospital, two of the top children’s hospitals in the nation, as our founding investors,” said Craig Manson, CEO of Configo Health. “These relationships go well beyond capital and will allow us to develop solutions that truly meet the needs of pediatric hospitals and their patients and families.”

Alec King, Chief Financial Officer of Children’s National Hospital added, “We invested in Configo Health because we believe they have the vision, experience and skills to revolutionize access to clear, actionable data across all functions within our institution.”

Stephanie Alexander, former President of Premier Analytics and most recently CEO of PeraHealth, the leading clinical decision support tool, will join Configo Health as Chair.

“I’m thrilled to join the talented Configo Health team at this exciting time in their development,” said Alexander. “Having pioneered the use of data as a driver for improvement and efficiency in adult care, I’m relishing the opportunity to be part of an organization set to transform the role data plays in pediatric medicine.”

About Configo Health, Inc.

Configo Health is a healthcare data and analytics company, focused specifically on pediatrics, that helps children’s hospitals and their patients and families make better decisions through the use of actionable insight. Experts in extracting administrative data from pediatric hospitals, Configo Health provides HIPPA compliant processes, secure data storage facilities, data cleansing and sophisticated analytical processing. Configo Health has offices in both New York and Washington D.C.

Share article on social media or email: